NIAID Pandemic Preparedness Plan Aims to Bolster Studies for ‘Prototype’ Pathogens
According to the National Institute of Allergy and Infectious Diseases' new Pandemic Preparedness Plan, the institute will direct its preparedness ...
According to the National Institute of Allergy and Infectious Diseases' new Pandemic Preparedness Plan, the institute will direct its preparedness ...
This model system will aid in understanding the severe disease course of COVID-19—including the virus’s interaction with the central nervous ...
The capsular antigen F1, the low-calcium-response V antigen (LcrV), and the recombinant fusion protein (rF1-LcrV) of Yersinia pestis, are leading ...
Pre-clinical studies published today in Science Translational Medicine indicate that the SpFN vaccine protects non-human primates from disease caused by ...
The findings point to the need for mRNA-1273 booster vaccination to sustain high-level and rapid protection in the lung and ...
NIH researchers evaluated the immune responses in nonhuman primates that received a primary vaccination series of mRNA-1273 (Moderna) and were ...
Vaccination yields broad neutralizing antibody responses against original strain and Beta, Gamma and Delta variants CiVax™ is under development as ...
In a promising result for the success of vaccines against COVID-19, rhesus macaque monkeys infected with the human coronavirus SARS-CoV-2 ...
Scientists at Texas Biomedical Research Institute and Southwest National Primate Research Center (SNPRC) published their findings regarding a comprehensive animal ...
The raging lung inflammation that can contribute to death from the flu can be stopped in its tracks by a ...
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. ...
Precision disease modeling involves creation of patient-specific disease models that mimic the molecular character of a condition present in a ...
Small animal models mirroring human disease are essential for advancing vaccines, diagnostics, and treatments to combat emerging pathogens. Army scientists ...
Thailand’s National Vaccine Institute (NVI) at Chulalongkorn University today began testing a trial vaccine against the novel coronavirus on non-human ...
An understanding of protective immunity to SARS-CoV-2 is critical for vaccine and public health strategies. A key unanswered question is ...
Study suggests standard laboratory mice may lead scientists to overestimate vaccine efficacy. A new study calls into question the reliance ...
An investigational vaccine called ChAdOx1 MERS protected two groups of rhesus macaques from disease caused by Middle East respiratory syndrome ...
Certain aspects of the pathogenesis of SARS-CoV-2 can only be studied in detail in animal models, where repeated sampling and ...
From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing ...
Burkholderia pseudomallei, the aetiological agent of melioidosis, causes a serious and often fatal disease in humans and animals. Novel medical ...